US Stock MarketDetailed Quotes

SPRB Spruce Biosciences

Watchlist
  • 0.337
  • +0.001+0.18%
Close Mar 21 16:00 ET
  • 0.337
  • +0.001+0.21%
Post 20:01 ET
13.90MMarket Cap-0.35P/E (TTM)

About Spruce Biosciences Company

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Company Profile

SymbolSPRB
Company NameSpruce Biosciences
Listing DateOct 9, 2020
Issue Price15.00
Founded2014
CEODr. Javier Szwarcberg, M.D.
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
Address611 Gateway Boulevard,Suite 740
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-415-655-4168
Websitehttp://www.sprucebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Javier Szwarcberg, M.D.
  • Chief Executive Officer and Director
  • 2.16M
  • Dr. Kirk Ways, M.D.,PhD
  • Independent Director and Interim Chief Medical Officer
  • 95.87K
  • Samir M. Gharib
  • Chief Financial Officer, Principal Accounting Officer and President
  • 1.20M
  • Dr. Ralph William Charlton, III
  • Chief Medical Officer
  • 1.00M
  • Michael Grey
  • Executive Chairman of the Board
  • 119.39K
  • Daniel K. Spiegelman
  • Independent Director
  • 106.89K
  • Dr. Niall O’Donnell, PhD
  • Independent Director
  • 96.89K
  • Camilla V. Simpson, M.Sc.
  • Independent Director
  • 98.39K
  • Dr. Bali Muralidhar, M.D.,PhD
  • Independent Director
  • 94.39K
  • Percival Barretto-Ko
  • Independent Director
  • 127.84K
  • Dr. Tiba Aynechi, PhD
  • Independent Director
  • 99.39K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Tesla
TSLA
248.710
Apple
AAPL
218.270
Meta Platforms
META
596.250
4
Microsoft
MSFT
391.260
5
Petroleo Brasileiro SA Petrobras
PBR
14.160
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.